Nuclear Medicine

Uzm. Dr. Aziz Nazaroğlu

Doctor and researcher Dr. İsmail Fehmi Cumalıoğlu Şehir Hastanesi Tekirdağ
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinesaglik.gov.trFrom source
  • InstitutionDr. İsmail Fehmi Cumalıoğlu Şehir Hastanesisaglik.gov.trFrom source
  • Publications10 publicationsORCIDFrom source
  • ORCID0000-0002-3052-9314ORCIDFrom source
  • Last synchronised5 November 2026 10:37https://tekirdagsehir.saglik.gov.tr/TR-584399/doktorlarimiz.html#aziz-nazaroglusaglik.gov.tr

Scientific work

Publications

10 publications

  1. Beyond tumor burden: PET/CT-derived psoas muscle quality and survival outcomes in metastatic NSCLC patients treated with nivolumab.

    BMC cancer, 2026

    DOI 10.1186/s12885-026-16210-z PMID 42192342 Open-access full textSource: ORCID

  2. Incidental Findings on 18F-Fluorocholine PET for Parathyroid Imaging

    European Journal of Nuclear Medicine and Molecular Imaging, 2023

    Source: ORCID

  3. The contribution of PET/MR in benign malignant nodule separation in thyroid incidentalomas detected in FDG PET/CT imaging

    European Journal of Nuclear Medicine and Molecular Imaging, 2022

    Source: ORCID

  4. Using Visual Recognition Based Machine Learning For The Prediction Of Survival In Patients With Colorectal Cancer With Liver Metastasis

    European Journal of Nuclear Medicine and Molecular Imaging, 2022

    Source: ORCID

  5. Can FDG PET Predict Covid 19 Disease Severity and Discharge Time

    European Journal of Nuclear Medicine and Molecular Imaging, 2021

    Source: ORCID

  6. Evaluation of thyroid function in patients receiving Lu-177 DOTATATE treatment

    European Journal of Nuclear Medicine and Molecular Imaging, 2021

    Source: ORCID

  7. Evaluation of treatment efficiency in 301 patients with hyperthyroidism treated with a single dose of I-131 as outpatient

    European Journal of Nuclear Medicine and Molecular Imaging, 2021

    Source: ORCID

  8. The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer

    European Journal of Nuclear Medicine and Molecular Imaging, 2020

    Source: ORCID

  9. The effectiveness of 177Lu-DOTATATE in patients with metastatic medullary thyroid cancer

    European Journal of Nuclear Medicine and Molecular Imaging, 2020

    Source: ORCID

  10. The efficacy of Lu177-PSMA treatment at chemotherapy-naive metastatic prostate cancer

    European Journal of Nuclear Medicine and Molecular Imaging, 2020

    Source: ORCID